Clinical outcomes of first line FOLFIRINOX vs . gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer at the Yale Smilow Hospital System

2021
    • Correction
    • Source
    • Cite
    • Save
    0
    References
    0
    Citations
    NaN
    KQI
    []
    Baidu
    map